Aqueduct Critical Care
2013
FOUNDED
PRIVATE
STATUS
Angel
LATEST DEAL TYPE
$822K
LATEST DEAL AMOUNT
16
INVESTORS
Description
Developer of medical devices designed to help in the treatment of neurological disease related to Cerebral Spinal Fluid (CSF). The company's medical devices are based upon traditional gravity-based drainage systems to allow for the automated regulation of ICP without the need for continuous manual measurements, adjustments and interventions, enabling hospital staff to easily conduct tests and physical therapy by providing their patients with mobility while draining.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Monitoring Equipment
Primary Office
- 11822 North Creek Parkway North
- Suite 110
- Bothell, WA 98011
- United States
+1 (855) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Aqueduct Critical Care’s full profile, request a free trial.
Aqueduct Critical Care Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Angel (individual) | 19-Jul-2018 | $822K | 000.00 | Completed | Generating Revenue | |
| 4. Early Stage VC (Series B) | 01-Nov-2017 | 000 | 00.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 01-Feb-2016 | 00.00 | 00.000 | 000.00 | Completed | Startup |
| 2. Early Stage VC (Series A) | 26-Aug-2015 | $3.71M | $3.71M | 00.000 | Completed | Startup |
| 1. Grant | $1.25M | Completed | Startup |
Aqueduct Critical Care Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Aqueduct Critical Care Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000000 | 07-Jul-2015 | 0000 00000 | 00000 | Specialized Finance |
Aqueduct Critical Care Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Heda Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Mighty Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SpringRock Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Wisemont Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Life Science Angels | Angel Group | Minority | 000 0000 | 000000 0 |
Aqueduct Critical Care Executive Team (6)
You’re viewing 5 of 6 executives. Get the full list »Aqueduct Critical Care Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ky Calder | Aqueduct Critical Care | Board Member | 000 0000 | |
| Richard Wohns | Aqueduct Critical Care | Board Member | 000 0000 | |
| Samuel Browd Ph.D | Aqueduct Critical Care | Co-Founder, Chief Medical Officer & Board Member | 000 0000 | |
| Sonya Erickson JD | Self | Board Member | 000 0000 | |
| Susan Preston | Aqueduct Critical Care | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 7 board members. Get the full list »